Concepedia

Stamatis Papathanasiou

SP

Statistics

Publications

7

Citations

951

H-Index

7

Active since

2015

Affiliations

Harvard University(Current)

Boston VA Research Institute

Dana-Farber Cancer Institute

Howard Hughes Medical Institute

AstraZeneca (United States)

Stamatis Papathanasiou is an author at Harvard University specializing in medicine, genetics, and genetic engineering.

ORCID

Top concepts

Publications per year

2015–2023

7

Publications

7

Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing

Mitchell L. Leibowitz, Stamatis Papathanasiou, Phillip A. Doerfler et al. · Nature Genetics · 2021 · 535 citations · Full text

, , +5

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing

Stamatis Papathanasiou, Styliani Markoulaki, Logan J. Blaine et al. · Nature Communications · 2021 · 134 citations · Full text

Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18

Stamatis Papathanasiou, Steffen Rickelt, María Eugenia Soriano et al. · Nature Medicine · 2015 · 104 citations · Full text

, , +9

Heritable transcriptional defects from aberrations of nuclear architecture

Stamatis Papathanasiou, Nikos A. Mynhier, Shiwei Liu et al. · Nature · 2023 · 79 citations · Full text

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing

Mitchell L. Leibowitz, Stamatis Papathanasiou, Phillip A. Doerfler et al. · 2020 · 63 citations · Full text

, , +20

1–5 of 7